Skip to main content

DnB Asset Management AS

SEC CIK
0001456670
Latest filing
Aug 11, 2026

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overviewAll 13F holders of TMOFull Q2 2026 holdings

Shares (Q2 2026)
117,013
Value
$58.7M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of TMO by DnB Asset Management AS, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026117,013$58.7M0.2%+3,148+2.8%AddedHolders
Q1 2026113,865$56.0M0.2%−642−0.6%ReducedHolders
Q4 2025114,507$66.4M0.2%−12,342−9.7%ReducedHolders
Q3 2025126,849$61.5M0.2%−12,465−8.9%ReducedHolders
Q2 2025139,314$56.5M0.2%−58,897−29.7%ReducedHolders
Q1 2025198,211$98.6M0.5%−3,070−1.5%ReducedHolders
Q4 2024201,281$104.7M0.5%+2,810+1.4%AddedHolders
Q3 2024198,471$122.8M0.6%+3,124+1.6%AddedHolders
Q2 2024195,347$108.0M0.5%+19,671+11.2%AddedHolders
Q1 2024175,676$102.1M0.5%−76,279−30.3%ReducedHolders
Q4 2023251,955$133.7M0.7%+203+0.1%AddedHolders
Q3 2023251,752$127.4M0.8%−795−0.3%ReducedHolders
Q2 2023252,547$131.8M0.8%+14,545+6.1%AddedHolders
Q1 2023238,002$137.2M0.9%−9,909−4.0%ReducedHolders
Q4 2022247,911$136.5M1.0%+4,084+1.7%AddedHolders
Q3 2022243,827$123.7M1.0%−7,469−3.0%ReducedHolders
Q2 2022251,296$136.5M1.0%+76,057+43.4%AddedHolders
Q1 2022175,239$103.5M0.6%−6,167−3.4%ReducedHolders
Q4 2021181,406$121.0M0.7%−2,280−1.2%ReducedHolders
Q3 2021183,686$104.9M0.7%+471+0.3%AddedHolders
Q2 2021183,215$92.4M0.6%+17,218+10.4%AddedHolders
Q1 2021165,997$75.8M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.